China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.05 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABUS Arbutus Biopharma Corp	$472M	$132,000 0.01% of portfolio	38,009	Q1 2025 Reduced 5.4%
CVAC Cure Vac N.V.	$1.02B	$124,000 0.01% of portfolio	44,998	Q1 2025 Reduced 5.4%
QURE Uni Qure N.V.	$666M	$122,000 0.01% of portfolio	11,574	Q1 2025 Added 4.63%
KALV Kal Vista Pharmaceuticals, Inc.	$389M	$114,000 0.01% of portfolio	9,912	Q1 2025 Reduced 4.04%
TRVI Trevi Therapeutics, Inc.	$396M	$112,000 0.01% of portfolio	17,925	Q1 2025 Added 9.98%
MGTX Meira G Tx Holdings PLC	$387M	$106,000 0.01% of portfolio	15,676	Q1 2025 Reduced 5.4%
KURA Kura Oncology, Inc.	$446M	$106,000 0.01% of portfolio	16,198	Q1 2025 Reduced 1.76%
SAGE Sage Therapeutics, Inc.	$520M	$98,000 0.01% of portfolio	12,332	Q1 2025 Reduced 4.93%
ARVN Arvinas, Inc.	$403M	$96,000 0.01% of portfolio	13,794	Q1 2025 Reduced 5.33%
OMER Omeros Corp	$235M	$95,000 0.01% of portfolio	11,624	Q1 2025 Reduced 5.4%
SVRA Savara Inc	$275M	$95,000 0.01% of portfolio	34,424	Q1 2025 Reduced 5.4%
TYRA Tyra Biosciences, Inc.	$432M	$94,000 0.01% of portfolio	10,150	Q1 2025 Reduced 5.41%
URGN Uro Gen Pharma Ltd.	$386M	$93,000 0.01% of portfolio	8,464	Q1 2025 Reduced 5.41%
RLAY Relay Therapeutics, Inc.	$446M	$89,000 0.01% of portfolio	34,003	Q1 2025 Reduced 4.19%
TBPH Theravance Biopharma, Inc.	$750M	$88,000 0.01% of portfolio	9,864	Q1 2025 Reduced 5.4%
CGEM Cullinan Oncology, Inc.	$370M	$88,000 0.01% of portfolio	11,737	Q1 2025 Reduced 4.93%
PGEN Precigen, Inc.	$316M	$87,000 0.01% of portfolio	58,744	Q1 2025 Reduced 5.4%
PHAT Phathom Pharmaceuticals, Inc.	$309M	$85,000 0.01% of portfolio	13,715	Q1 2025 Reduced 5.41%
KROS Keros Therapeutics, Inc.	$354M	$82,000 0.01% of portfolio	8,136	Q1 2025 Reduced 5.27%
VERV Verve Therapeutics, Inc.	$664M	$81,000 0.01% of portfolio	17,811	Q1 2025 Reduced 0.79%
ORIC Oric Pharmaceuticals, Inc.	$441M	$79,000 0.01% of portfolio	14,247	Q1 2025 Reduced 4.79%
ERAS Erasca, Inc.	$205M	$77,000 0.01% of portfolio	56,710	Q1 2025 Reduced 5.4%
ALT Altimmune, Inc.	$206M	$77,000 0.01% of portfolio	15,448	Q1 2025 Added 2.43%
SANA Sana Biotechnology, Inc.	$926M	$75,000 0.01% of portfolio	44,784	Q1 2025 Reduced 5.4%
BCYC Bicycle Therapeutics PLC	$248M	$74,000 0.01% of portfolio	8,833	Q1 2025 Reduced 5.32%
CRMD Cor Medix Inc.	$459M	$74,000 0.01% of portfolio	12,171	Q1 2025 Reduced 5.4%
EYPT Eye Point Pharmaceuticals, Inc.	$356M	$74,000 0.01% of portfolio	13,690	Q1 2025 Reduced 5.4%
GLPG Galapagos Nv	$2.16B	$73,000 0.01% of portfolio	2,931	Q1 2025 Reduced 1.05%
RGNX Regenxbio Inc.	$370M	$71,000 0.01% of portfolio	9,938	Q1 2025 Reduced 5.4%
STOK Stoke Therapeutics, Inc.	$535M	$70,000 0.01% of portfolio	10,624	Q1 2025 Reduced 5.4%
TRDA Entrada Therapeutics, Inc.	$200M	$68,000 0.01% of portfolio	7,541	Q1 2025 Reduced 4.92%
MRVI Maravai Lifesciences Holdings, Inc.	$333M	$62,000 0.01% of portfolio	28,451	Q1 2025 Reduced 5.4%
AUTL Autolus Therapeutics PLC	$237M	$62,000 0.01% of portfolio	40,200	Q1 2025 Reduced 5.07%
ALLO Allogene Therapeutics, Inc.	$204M	$61,000 0.01% of portfolio	42,057	Q1 2025 Reduced 5.4%
AMLX Amylyx Pharmaceuticals, Inc.	$461M	$60,000 0.01% of portfolio	17,188	Q1 2025 Added 18.25%
ATXS Astria Therapeutics, Inc.	$94.6M	$60,000 0.01% of portfolio	11,320	Q1 2025 Reduced 5.4%
AURA Aura Biosciences, Inc.	$198M	$58,000 0.01% of portfolio	10,019	Q1 2025 Reduced 5.41%
ARCT Arcturus Therapeutics Holdings Inc.	$386M	$57,000 0.01% of portfolio	5,433	Q1 2025 Reduced 5.41%
GLUE Monte Rosa Therapeutics, Inc.	$264M	$57,000 0.01% of portfolio	12,323	Q1 2025 Reduced 5.4%
ABSI Absci Corp	$337M	$57,000 0.01% of portfolio	23,038	Q1 2025 Reduced 5.4%
TSHA Taysha Gene Therapies, Inc.	$126M	$57,000 0.01% of portfolio	41,120	Q1 2025 Reduced 5.38%
ELYM Eliem Therapeutics, Inc.	$109M	$55,000 0.01% of portfolio	13,484	Q1 2025 Reduced 5.4%
OLMA Olema Pharmaceuticals, Inc.	$184M	$55,000 0.01% of portfolio	14,892	Q1 2025 Added 22.58%
VNDA Vanda Pharmaceuticals Inc.	$266M	$53,000 0.01% of portfolio	11,697	Q1 2025 Reduced 5.39%
KMPH Kempharm, Inc	$170M	$52,000 0.0% of portfolio	10,706	Q1 2025 Reduced 5.41%
TSVT 2seventy Bio, Inc.	$189M	$51,000 0.0% of portfolio	10,348	Q1 2025 Reduced 5.4%
AVIR Atea Pharmaceuticals, Inc.	$286M	$50,000 0.0% of portfolio	16,942	Q1 2025 Reduced 5.4%
TERN Terns Pharmaceuticals, Inc.	$216M	$47,000 0.0% of portfolio	17,037	Q1 2025 Reduced 5.4%
CDXS Codexis, Inc.	$200M	$44,000 0.0% of portfolio	16,616	Q1 2025 Reduced 3.7%
HUMA Humacyte, Inc.	$237M	$44,000 0.0% of portfolio	25,809	Q1 2025 Reduced 5.4%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.